Edges in Network
Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | SLC7A5 |
Upstream (Parents) |
---|
(<<) ASNS → SLC7A5 |
(<<) CCNB2 → SLC7A5 |
(<<) CCNE1 → SLC7A5 |
(<<) CEBPB → SLC7A5 |
(<<) CTPS → SLC7A5 |
(<<) DDX21 → SLC7A5 |
(<<) E2F3 → SLC7A5 |
(<<) FAM136A → SLC7A5 |
(<<) IGFBP4 → SLC7A5 |
(<<) LRP8 → SLC7A5 |
(<<) MLPH → SLC7A5 |
(<<) MTHFD2 → SLC7A5 |
(<<) ORC6L → SLC7A5 |
(<<) PHGDH → SLC7A5 |
(<<) PSAT1 → SLC7A5 |
(<<) RNASE4 → SLC7A5 |
(<<) SPAG5 → SLC7A5 |
(<<) STC2 → SLC7A5 |
(<<) TUBA1B → SLC7A5 |
(<<) TUBA1C → SLC7A5 |
(<<) UBE2C → SLC7A5 |
Downstream (Children) |
---|
SLC7A5 → CBS (>>) |
SLC7A5 → CCNA1 (>>) |
SLC7A5 → CDK6 (>>) |
SLC7A5 → CDKN2A (>>) |
SLC7A5 → DHCR7 (>>) |
SLC7A5 → DUSP4 (>>) |
SLC7A5 → E2F4 (>>) |
SLC7A5 → EIF4EBP1 (>>) |
SLC7A5 → EMG1 (>>) |
SLC7A5 → EN2 (>>) |
SLC7A5 → FERMT1 (>>) |
SLC7A5 → GAD1 (>>) |
SLC7A5 → GAPDH (>>) |
SLC7A5 → GSTM3 (>>) |
SLC7A5 → IRAK1 (>>) |
SLC7A5 → ITPR1 (>>) |
SLC7A5 → KCNK1 (>>) |
SLC7A5 → KHDRBS1 (>>) |
SLC7A5 → MAP3K12 (>>) |
SLC7A5 → MAP3K3 (>>) |
SLC7A5 → MAPK12 (>>) |
SLC7A5 → MMP1 (>>) |
SLC7A5 → MPHOSPH6 (>>) |
SLC7A5 → MYL7 (>>) |
SLC7A5 → MYO10 (>>) |
SLC7A5 → NMU (>>) |
SLC7A5 → NXT1 (>>) |
SLC7A5 → PLAT (>>) |
SLC7A5 → PLK1 (>>) |
SLC7A5 → PRDX6 (>>) |
SLC7A5 → PTGS2 (>>) |
SLC7A5 → PTPLA (>>) |
SLC7A5 → SESN1 (>>) |
SLC7A5 → SHC2 (>>) |
SLC7A5 → SPRR2C (>>) |
SLC7A5 → STAT5B (>>) |
SLC7A5 → TK1 (>>) |
SLC7A5 → TMSB10 (>>) |
SLC7A5 → TNFRSF1A (>>) |
SLC7A5 → TPSG1 (>>) |
SLC7A5 → WNT7B (>>) |